Adalimumab for induction of remission in Crohn's disease-Reference-Cited by-同舟云学术

Adalimumab for induction of remission in Crohn's disease

Published:2017-11-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Abbass Mohamad¹,Cepek Jeremy¹,Parker Claire E²,Nguyen Tran M³,MacDonald John K³⁴,Feagan Brian G²³⁴⁵,Khanna Reena²⁴,Jairath Vipul²⁴⁵

Affiliation:

1. University of Western Ontario; Schulich School of Medicine & Dentistry; London Ontario Canada

2. Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

3. Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada

4. University of Western Ontario; Department of Medicine; London ON Canada

5. University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference19 articles.

1. Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial;Asgharpour;Clinical and Experimental Gastroenterology,2013

2. Crohn's disease;Baumgart;Lancet,2012

3. Adalimumab for the treatment of Crohn's disease;Cassinotti;Biologics,2008

4. Bias in meta-analysis detected by a simple, graphical test;Egger;BMJ,1997

5. FDA Humira highlights of prescribing information www.accessdata.fda.gov/drugsatfda_docs/label/2008/125057s0110lbl.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease;Cochrane Database of Systematic Reviews;2021-10-31